CRISPR Therapeutics AG
CRSP | NASDAQ
$51.40
-$2.86 (-5.27%)
At close: Oct 30, 2026, 3:59 PM ET
$51.70
+$0.30 (+0.58%)
Pre-market:
Nov 2, 2026, 8:03 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 355.19M | 298.26M | 389.48M | 211.89M | 923.03M | 1.17B |
Short-Term Investments | 1.63B | 1.61B | 1.3B | 1.6B | 1.46B | 521.71M |
Long-Term Investments | n/a | n/a | 1.97M | 53.13M | n/a | n/a |
Other Long-Term Assets | 32M | 27.35M | 13.57M | 16.28M | 22.2M | 18.14M |
Receivables | n/a | 25M | 200M | n/a | 305K | 10.84M |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 9.84M | 8.31M | 6.5M | 11.7M | 8.4M | n/a |
Total Current Assets | 1.99B | 1.94B | 1.91B | 1.85B | 2.42B | 1.72B |
Property-Plant & Equipment | 247.58M | 277.55M | 305.94M | 320.56M | 312.04M | 93.03M |
Goodwill & Intangibles | n/a | n/a | 16K | 71K | 125K | 180K |
Total Long-Term Assets | 279.57M | 304.9M | 321.49M | 390.03M | 334.36M | 111.35M |
Total Assets | 2.27B | 2.24B | 2.23B | 2.24B | 2.75B | 1.83B |
Account Payables | 11.14M | 14.71M | 38.15M | 27.43M | 14.82M | 9.09M |
Deferred Revenue | 15.77M | 3.85M | 4.11M | n/a | 1.01M | 2.34M |
Short-Term Debt | 18.58M | 17.29M | 15.63M | 15.84M | 12.16M | 11.36M |
Other Current Liabilities | 89.55M | 33.05M | 33.13M | 58.46M | 67.51M | 38.59M |
Total Current Liabilities | 149.12M | 87.78M | 108.79M | 121.11M | 119.88M | 94.26M |
Long-Term Debt | 188.17M | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | -182.03M | 3.44M | 958K | 5.97M | 7.34M | 7.63M |
Total Long-Term Liabilities | 194.31M | 222.17M | 237.98M | 246.47M | 232.53M | 69.47M |
Total Liabilities | 343.43M | 309.95M | 346.77M | 367.58M | 352.42M | 163.73M |
Total Debt | 394.91M | 223.69M | 238.63M | 244.02M | 225.03M | 61.43M |
Book Value | 1.92B | 1.93B | 1.88B | 1.88B | 2.4B | 1.66B |
Book Value Per Share | 21.37 | 22.90 | 23.77 | 24.12 | 29.85 | 25.23 |
Common Stock | 3.09M | 2.7M | 2.5M | 2.44M | 2.39M | 2.28M |
Retained Earnings | -1.95B | -1.37B | -999.7M | -846.09M | -195.92M | -573.58M |
Comprehensive Income | 4.82M | 1.84M | 1.91M | -15.65M | -5.07M | -83K |
Shareholders Equity | 1.92B | 1.93B | 1.88B | 1.88B | 2.4B | 1.66B |
Total Investments | 1.63B | 1.61B | 1.31B | 1.66B | 1.46B | 521.71M |
Add to Watchlist
Select watchlists to add or remove CRSP